Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:urine protein test result documented and reviewed'
(id=8087859 ; fe=en:urine protein test result documented and reviewed ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=5833 creation date=2017-07-21 touchdate=2025-05-10 18:59:17.000)
≈ 182 relations sortantes

  1. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression
    n1=en:urine protein test result documented and reviewed | n2=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | rel=r_associated | relid=0 | w=30
  2. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:counseling for diet and physical activity performed
    n1=en:urine protein test result documented and reviewed | n2=en:counseling for diet and physical activity performed | rel=r_associated | relid=0 | w=30
  3. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=30
  4. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | rel=r_associated | relid=0 | w=30
  5. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | rel=r_associated | relid=0 | w=30
  6. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:injection, taliglucerase alfa, 10 units
    n1=en:urine protein test result documented and reviewed | n2=en:injection, taliglucerase alfa, 10 units | rel=r_associated | relid=0 | w=30
  7. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:injection, ziv-aflibercept, 1 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, ziv-aflibercept, 1 mg | rel=r_associated | relid=0 | w=30
  8. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:level of activity and symptoms not assessed
    n1=en:urine protein test result documented and reviewed | n2=en:level of activity and symptoms not assessed | rel=r_associated | relid=0 | w=30
  9. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | rel=r_associated | relid=0 | w=30
  10. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:patient documentation - angina assessed as absent
    n1=en:urine protein test result documented and reviewed | n2=en:patient documentation - angina assessed as absent | rel=r_associated | relid=0 | w=30
  11. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:patient not treated for memory disorder
    n1=en:urine protein test result documented and reviewed | n2=en:patient not treated for memory disorder | rel=r_associated | relid=0 | w=30
  12. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:patient not treated for motor speech disorder
    n1=en:urine protein test result documented and reviewed | n2=en:patient not treated for motor speech disorder | rel=r_associated | relid=0 | w=30
  13. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=30
  14. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:prednisone, oral, per 5 mg
    n1=en:urine protein test result documented and reviewed | n2=en:prednisone, oral, per 5 mg | rel=r_associated | relid=0 | w=30
  15. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)
    n1=en:urine protein test result documented and reviewed | n2=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=30
  16. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:score on the writing functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the writing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=30
  17. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:suicide risk not assessed at the initial evaluation, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:suicide risk not assessed at the initial evaluation, reason not given | rel=r_associated | relid=0 | w=30
  18. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
    n1=en:urine protein test result documented and reviewed | n2=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | rel=r_associated | relid=0 | w=30
  19. en:urine protein test result documented and reviewed -- r_associated #0: 30 / 1 -> en:urine protein test was not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:urine protein test was not performed, reason not given | rel=r_associated | relid=0 | w=30
  20. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:antiplatelet medication contraindicated
    n1=en:urine protein test result documented and reviewed | n2=en:antiplatelet medication contraindicated | rel=r_associated | relid=0 | w=29
  21. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
    n1=en:urine protein test result documented and reviewed | n2=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | rel=r_associated | relid=0 | w=29
  22. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | rel=r_associated | relid=0 | w=29
  23. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy
    n1=en:urine protein test result documented and reviewed | n2=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | rel=r_associated | relid=0 | w=29
  24. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | rel=r_associated | relid=0 | w=29
  25. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
    n1=en:urine protein test result documented and reviewed | n2=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | rel=r_associated | relid=0 | w=29
  26. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery
    n1=en:urine protein test result documented and reviewed | n2=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | rel=r_associated | relid=0 | w=29
  27. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:urine protein test result documented and reviewed | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  28. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents
    n1=en:urine protein test result documented and reviewed | n2=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | rel=r_associated | relid=0 | w=29
  29. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:pregnancy test (urine or serum) not ordered for reasons documented by clinician
    n1=en:urine protein test result documented and reviewed | n2=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | rel=r_associated | relid=0 | w=29
  30. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer
    n1=en:urine protein test result documented and reviewed | n2=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=29
  31. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries
    n1=en:urine protein test result documented and reviewed | n2=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | rel=r_associated | relid=0 | w=29
  32. en:urine protein test result documented and reviewed -- r_associated #0: 29 / 0.967 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)
    n1=en:urine protein test result documented and reviewed | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | rel=r_associated | relid=0 | w=29
  33. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=28
  34. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=28
  35. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:urine protein test result documented and reviewed | n2=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=28
  36. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:genetic testing for gaucher disease
    n1=en:urine protein test result documented and reviewed | n2=en:genetic testing for gaucher disease | rel=r_associated | relid=0 | w=28
  37. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:i intend to report the back pain measures group
    n1=en:urine protein test result documented and reviewed | n2=en:i intend to report the back pain measures group | rel=r_associated | relid=0 | w=28
  38. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:injection, ferric carboxymaltose, 1 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, ferric carboxymaltose, 1 mg | rel=r_associated | relid=0 | w=28
  39. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:injection, medroxyprogesterone acetate, 50 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, medroxyprogesterone acetate, 50 mg | rel=r_associated | relid=0 | w=28
  40. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | rel=r_associated | relid=0 | w=28
  41. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:injection, testosterone enanthate, up to 100 mg administered
    n1=en:urine protein test result documented and reviewed | n2=en:injection, testosterone enanthate, up to 100 mg administered | rel=r_associated | relid=0 | w=28
  42. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:oral aspirin or other antithrombotic therapy prescribed
    n1=en:urine protein test result documented and reviewed | n2=en:oral aspirin or other antithrombotic therapy prescribed | rel=r_associated | relid=0 | w=28
  43. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:urine protein test result documented and reviewed | n2=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=28
  44. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:patients with a positive hepatitis c antibody test
    n1=en:urine protein test result documented and reviewed | n2=en:patients with a positive hepatitis c antibody test | rel=r_associated | relid=0 | w=28
  45. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:score on the attention functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the attention functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=28
  46. en:urine protein test result documented and reviewed -- r_associated #0: 28 / 0.933 -> en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
    n1=en:urine protein test result documented and reviewed | n2=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=28
  47. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:abdominal aortic aneurysm is not infarenal
    n1=en:urine protein test result documented and reviewed | n2=en:abdominal aortic aneurysm is not infarenal | rel=r_associated | relid=0 | w=27
  48. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:beta-blocker at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:beta-blocker at discharge | rel=r_associated | relid=0 | w=27
  49. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet
    n1=en:urine protein test result documented and reviewed | n2=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | rel=r_associated | relid=0 | w=27
  50. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:diabetes screening test not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:diabetes screening test not performed, reason not given | rel=r_associated | relid=0 | w=27
  51. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=27
  52. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:grafix prime, per square centimeter
    n1=en:urine protein test result documented and reviewed | n2=en:grafix prime, per square centimeter | rel=r_associated | relid=0 | w=27
  53. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
    n1=en:urine protein test result documented and reviewed | n2=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | rel=r_associated | relid=0 | w=27
  54. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:injection, human fibrinogen concentrate, 100 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, human fibrinogen concentrate, 100 mg | rel=r_associated | relid=0 | w=27
  55. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:injection, testosterone enanthate, up to 200 mg administered
    n1=en:urine protein test result documented and reviewed | n2=en:injection, testosterone enanthate, up to 200 mg administered | rel=r_associated | relid=0 | w=27
  56. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:ldl-c not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:ldl-c not performed, reason not given | rel=r_associated | relid=0 | w=27
  57. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason
    n1=en:urine protein test result documented and reviewed | n2=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | rel=r_associated | relid=0 | w=27
  58. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:miscellaneous supply or accessory for use with ventricular assist device
    n1=en:urine protein test result documented and reviewed | n2=en:miscellaneous supply or accessory for use with ventricular assist device | rel=r_associated | relid=0 | w=27
  59. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:most recent ldl-c under control, results documented and reviewed
    n1=en:urine protein test result documented and reviewed | n2=en:most recent ldl-c under control, results documented and reviewed | rel=r_associated | relid=0 | w=27
  60. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:most recent office visit diastolic blood pressure, 80 - 89 mm hg
    n1=en:urine protein test result documented and reviewed | n2=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | rel=r_associated | relid=0 | w=27
  61. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:patient not treated for spoken language expression disorder
    n1=en:urine protein test result documented and reviewed | n2=en:patient not treated for spoken language expression disorder | rel=r_associated | relid=0 | w=27
  62. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:patient receiving antiviral treatment for hepatitis c documented
    n1=en:urine protein test result documented and reviewed | n2=en:patient receiving antiviral treatment for hepatitis c documented | rel=r_associated | relid=0 | w=27
  63. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase
    n1=en:urine protein test result documented and reviewed | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | rel=r_associated | relid=0 | w=27
  64. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel
    n1=en:urine protein test result documented and reviewed | n2=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | rel=r_associated | relid=0 | w=27
  65. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:vacuum drainage bottle and tubing for use with implanted catheter
    n1=en:urine protein test result documented and reviewed | n2=en:vacuum drainage bottle and tubing for use with implanted catheter | rel=r_associated | relid=0 | w=27
  66. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)
    n1=en:urine protein test result documented and reviewed | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=27
  67. en:urine protein test result documented and reviewed -- r_associated #0: 27 / 0.9 -> protéine
    n1=en:urine protein test result documented and reviewed | n2=protéine | rel=r_associated | relid=0 | w=27
  68. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient
    n1=en:urine protein test result documented and reviewed | n2=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | rel=r_associated | relid=0 | w=26
  69. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:counseling for diet and physical activity not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:counseling for diet and physical activity not performed, reason not given | rel=r_associated | relid=0 | w=26
  70. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes
    n1=en:urine protein test result documented and reviewed | n2=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | rel=r_associated | relid=0 | w=26
  71. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:documentation of diagnosis of chronic kidney disease
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of diagnosis of chronic kidney disease | rel=r_associated | relid=0 | w=26
  72. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
    n1=en:urine protein test result documented and reviewed | n2=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | rel=r_associated | relid=0 | w=26
  73. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
    n1=en:urine protein test result documented and reviewed | n2=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | rel=r_associated | relid=0 | w=26
  74. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed
    n1=en:urine protein test result documented and reviewed | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | rel=r_associated | relid=0 | w=26
  75. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:genetic testing for canavan disease
    n1=en:urine protein test result documented and reviewed | n2=en:genetic testing for canavan disease | rel=r_associated | relid=0 | w=26
  76. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:i intend to report the hypertension (htn) measures group
    n1=en:urine protein test result documented and reviewed | n2=en:i intend to report the hypertension (htn) measures group | rel=r_associated | relid=0 | w=26
  77. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
    n1=en:urine protein test result documented and reviewed | n2=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | rel=r_associated | relid=0 | w=26
  78. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:most recent ldl-c not under control, results documented and reviewed
    n1=en:urine protein test result documented and reviewed | n2=en:most recent ldl-c not under control, results documented and reviewed | rel=r_associated | relid=0 | w=26
  79. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:urine protein test result documented and reviewed | n2=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=26
  80. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | rel=r_associated | relid=0 | w=26
  81. en:urine protein test result documented and reviewed -- r_associated #0: 26 / 0.867 -> en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | rel=r_associated | relid=0 | w=26
  82. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:assessed level of activity and symptoms
    n1=en:urine protein test result documented and reviewed | n2=en:assessed level of activity and symptoms | rel=r_associated | relid=0 | w=25
  83. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=25
  84. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
    n1=en:urine protein test result documented and reviewed | n2=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | rel=r_associated | relid=0 | w=25
  85. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.)
    n1=en:urine protein test result documented and reviewed | n2=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | rel=r_associated | relid=0 | w=25
  86. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:injection, brentuximab vedotin, 1 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, brentuximab vedotin, 1 mg | rel=r_associated | relid=0 | w=25
  87. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:injection, morphine sulfate, 100mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, morphine sulfate, 100mg | rel=r_associated | relid=0 | w=25
  88. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:injection, zoledronic acid (zometa), 1 mg administered
    n1=en:urine protein test result documented and reviewed | n2=en:injection, zoledronic acid (zometa), 1 mg administered | rel=r_associated | relid=0 | w=25
  89. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:most recent blood pressure under control
    n1=en:urine protein test result documented and reviewed | n2=en:most recent blood pressure under control | rel=r_associated | relid=0 | w=25
  90. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:patch closure used for patient undergoing conventional cea
    n1=en:urine protein test result documented and reviewed | n2=en:patch closure used for patient undergoing conventional cea | rel=r_associated | relid=0 | w=25
  91. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase
    n1=en:urine protein test result documented and reviewed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | rel=r_associated | relid=0 | w=25
  92. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine
    n1=en:urine protein test result documented and reviewed | n2=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | rel=r_associated | relid=0 | w=25
  93. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:positive airway pressure therapy not prescribed
    n1=en:urine protein test result documented and reviewed | n2=en:positive airway pressure therapy not prescribed | rel=r_associated | relid=0 | w=25
  94. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:prescription(s) generated and transmitted via a qualified erx system
    n1=en:urine protein test result documented and reviewed | n2=en:prescription(s) generated and transmitted via a qualified erx system | rel=r_associated | relid=0 | w=25
  95. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:urine protein test result documented and reviewed | n2=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=25
  96. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge
    n1=en:urine protein test result documented and reviewed | n2=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | rel=r_associated | relid=0 | w=25
  97. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=25
  98. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
    n1=en:urine protein test result documented and reviewed | n2=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=25
  99. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
    n1=en:urine protein test result documented and reviewed | n2=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=25
  100. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
    n1=en:urine protein test result documented and reviewed | n2=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=25
  101. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device
    n1=en:urine protein test result documented and reviewed | n2=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | rel=r_associated | relid=0 | w=25
  102. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:urine
    n1=en:urine protein test result documented and reviewed | n2=en:urine | rel=r_associated | relid=0 | w=25
  103. en:urine protein test result documented and reviewed -- r_associated #0: 25 / 0.833 -> en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
    n1=en:urine protein test result documented and reviewed | n2=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | rel=r_associated | relid=0 | w=25
  104. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:anti-lipid treatment at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=24
  105. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:electronic wrist rotator, otto bock or equal
    n1=en:urine protein test result documented and reviewed | n2=en:electronic wrist rotator, otto bock or equal | rel=r_associated | relid=0 | w=24
  106. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
    n1=en:urine protein test result documented and reviewed | n2=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | rel=r_associated | relid=0 | w=24
  107. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis performed
    n1=en:urine protein test result documented and reviewed | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | rel=r_associated | relid=0 | w=24
  108. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes
    n1=en:urine protein test result documented and reviewed | n2=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | rel=r_associated | relid=0 | w=24
  109. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:i intend to report the epilepsy measures group
    n1=en:urine protein test result documented and reviewed | n2=en:i intend to report the epilepsy measures group | rel=r_associated | relid=0 | w=24
  110. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered
    n1=en:urine protein test result documented and reviewed | n2=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | rel=r_associated | relid=0 | w=24
  111. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:injection, ocriplasmin, 0.125 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, ocriplasmin, 0.125 mg | rel=r_associated | relid=0 | w=24
  112. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:patient documentation - angina assessed as present
    n1=en:urine protein test result documented and reviewed | n2=en:patient documentation - angina assessed as present | rel=r_associated | relid=0 | w=24
  113. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:patient not treated for reading disorder
    n1=en:urine protein test result documented and reviewed | n2=en:patient not treated for reading disorder | rel=r_associated | relid=0 | w=24
  114. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:pneumocystis jiroveci pneumonia prophlaxis prescribed
    n1=en:urine protein test result documented and reviewed | n2=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | rel=r_associated | relid=0 | w=24
  115. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:rehabilitation services were not ordered, reason not otherwise specified
    n1=en:urine protein test result documented and reviewed | n2=en:rehabilitation services were not ordered, reason not otherwise specified | rel=r_associated | relid=0 | w=24
  116. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:score on the spoken language expression functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=24
  117. en:urine protein test result documented and reviewed -- r_associated #0: 24 / 0.8 -> en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens
    n1=en:urine protein test result documented and reviewed | n2=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | rel=r_associated | relid=0 | w=24
  118. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:compounded drug, not otherwise classified
    n1=en:urine protein test result documented and reviewed | n2=en:compounded drug, not otherwise classified | rel=r_associated | relid=0 | w=23
  119. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month
    n1=en:urine protein test result documented and reviewed | n2=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | rel=r_associated | relid=0 | w=23
  120. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=23
  121. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:i intend to report the community-acquired pneumonia (cap) measures group
    n1=en:urine protein test result documented and reviewed | n2=en:i intend to report the community-acquired pneumonia (cap) measures group | rel=r_associated | relid=0 | w=23
  122. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
    n1=en:urine protein test result documented and reviewed | n2=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | rel=r_associated | relid=0 | w=23
  123. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:injection, peginesatide, 0.1 mg (for esrd on dialysis)
    n1=en:urine protein test result documented and reviewed | n2=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | rel=r_associated | relid=0 | w=23
  124. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:ldl-c was not performed
    n1=en:urine protein test result documented and reviewed | n2=en:ldl-c was not performed | rel=r_associated | relid=0 | w=23
  125. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:lipid profile not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:lipid profile not performed, reason not given | rel=r_associated | relid=0 | w=23
  126. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:urine protein test result documented and reviewed | n2=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=23
  127. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | rel=r_associated | relid=0 | w=23
  128. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:urine protein test result documented and reviewed | n2=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=23
  129. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:score on the swallowing functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the swallowing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=23
  130. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:serum creatinine test not performed, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:serum creatinine test not performed, reason not given | rel=r_associated | relid=0 | w=23
  131. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:suicide risk assessed at the initial evaluation
    n1=en:urine protein test result documented and reviewed | n2=en:suicide risk assessed at the initial evaluation | rel=r_associated | relid=0 | w=23
  132. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals
    n1=en:urine protein test result documented and reviewed | n2=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | rel=r_associated | relid=0 | w=23
  133. en:urine protein test result documented and reviewed -- r_associated #0: 23 / 0.767 -> en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])
    n1=en:urine protein test result documented and reviewed | n2=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=23
  134. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed
    n1=en:urine protein test result documented and reviewed | n2=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | rel=r_associated | relid=0 | w=22
  135. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:urine protein test result documented and reviewed | n2=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=22
  136. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)
    n1=en:urine protein test result documented and reviewed | n2=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | rel=r_associated | relid=0 | w=22
  137. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:injection, sculptra, 0.1 ml
    n1=en:urine protein test result documented and reviewed | n2=en:injection, sculptra, 0.1 ml | rel=r_associated | relid=0 | w=22
  138. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:injection, sulfur hexafluoride lipid microsphere, per ml
    n1=en:urine protein test result documented and reviewed | n2=en:injection, sulfur hexafluoride lipid microsphere, per ml | rel=r_associated | relid=0 | w=22
  139. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:injection, testosterone cypionate, up to 100 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, testosterone cypionate, up to 100 mg | rel=r_associated | relid=0 | w=22
  140. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed
    n1=en:urine protein test result documented and reviewed | n2=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | rel=r_associated | relid=0 | w=22
  141. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:levonorgestrel 52mg intrauterine system
    n1=en:urine protein test result documented and reviewed | n2=en:levonorgestrel 52mg intrauterine system | rel=r_associated | relid=0 | w=22
  142. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a
    n1=en:urine protein test result documented and reviewed | n2=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | rel=r_associated | relid=0 | w=22
  143. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:no anti-lipid treatment at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:no anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=22
  144. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb)
    n1=en:urine protein test result documented and reviewed | n2=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | rel=r_associated | relid=0 | w=22
  145. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility
    n1=en:urine protein test result documented and reviewed | n2=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | rel=r_associated | relid=0 | w=22
  146. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | rel=r_associated | relid=0 | w=22
  147. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches
    n1=en:urine protein test result documented and reviewed | n2=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | rel=r_associated | relid=0 | w=22
  148. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:prostate cancer antigen 3 (pca3) testing
    n1=en:urine protein test result documented and reviewed | n2=en:prostate cancer antigen 3 (pca3) testing | rel=r_associated | relid=0 | w=22
  149. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:score on the motor speech functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the motor speech functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=22
  150. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:score on the reading functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the reading functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=22
  151. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:severity of angina assessed according to level of activity
    n1=en:urine protein test result documented and reviewed | n2=en:severity of angina assessed according to level of activity | rel=r_associated | relid=0 | w=22
  152. en:urine protein test result documented and reviewed -- r_associated #0: 22 / 0.733 -> en:unlisted procedure, intestine
    n1=en:urine protein test result documented and reviewed | n2=en:unlisted procedure, intestine | rel=r_associated | relid=0 | w=22
  153. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation)
    n1=en:urine protein test result documented and reviewed | n2=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | rel=r_associated | relid=0 | w=21
  154. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
    n1=en:urine protein test result documented and reviewed | n2=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=21
  155. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer
    n1=en:urine protein test result documented and reviewed | n2=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=21
  156. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:complete gene sequence analysis; mlh1 gene
    n1=en:urine protein test result documented and reviewed | n2=en:complete gene sequence analysis; mlh1 gene | rel=r_associated | relid=0 | w=21
  157. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:urine protein test result documented and reviewed | n2=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=21
  158. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record
    n1=en:urine protein test result documented and reviewed | n2=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | rel=r_associated | relid=0 | w=21
  159. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:fluocinolone acetonide, intravitreal implant
    n1=en:urine protein test result documented and reviewed | n2=en:fluocinolone acetonide, intravitreal implant | rel=r_associated | relid=0 | w=21
  160. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:hcpcs level ii preferred terms, obsolete
    n1=en:urine protein test result documented and reviewed | n2=en:hcpcs level ii preferred terms, obsolete | rel=r_associated | relid=0 | w=21
  161. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:i intend to report the perioperative care measures group
    n1=en:urine protein test result documented and reviewed | n2=en:i intend to report the perioperative care measures group | rel=r_associated | relid=0 | w=21
  162. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit
    n1=en:urine protein test result documented and reviewed | n2=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | rel=r_associated | relid=0 | w=21
  163. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)
    n1=en:urine protein test result documented and reviewed | n2=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | rel=r_associated | relid=0 | w=21
  164. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:injection, alemtuzumab, 10 mg administered
    n1=en:urine protein test result documented and reviewed | n2=en:injection, alemtuzumab, 10 mg administered | rel=r_associated | relid=0 | w=21
  165. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:injection, factor viii, fc fusion protein, (recombinant), per i.u.
    n1=en:urine protein test result documented and reviewed | n2=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | rel=r_associated | relid=0 | w=21
  166. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:netupitant 300 mg and palonosetron 0.5 mg
    n1=en:urine protein test result documented and reviewed | n2=en:netupitant 300 mg and palonosetron 0.5 mg | rel=r_associated | relid=0 | w=21
  167. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:no documentation of disease type, anatomic location, and activity, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:no documentation of disease type, anatomic location, and activity, reason not given | rel=r_associated | relid=0 | w=21
  168. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
    n1=en:urine protein test result documented and reviewed | n2=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | rel=r_associated | relid=0 | w=21
  169. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:patient had a medical visit in the last 6 months
    n1=en:urine protein test result documented and reviewed | n2=en:patient had a medical visit in the last 6 months | rel=r_associated | relid=0 | w=21
  170. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:patient not treated for attention disorder
    n1=en:urine protein test result documented and reviewed | n2=en:patient not treated for attention disorder | rel=r_associated | relid=0 | w=21
  171. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge
    n1=en:urine protein test result documented and reviewed | n2=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=21
  172. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:pregnancy test (urine or serum) was not ordered, reason not specified
    n1=en:urine protein test result documented and reviewed | n2=en:pregnancy test (urine or serum) was not ordered, reason not specified | rel=r_associated | relid=0 | w=21
  173. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=21
  174. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=21
  175. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission
    n1=en:urine protein test result documented and reviewed | n2=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=21
  176. en:urine protein test result documented and reviewed -- r_associated #0: 21 / 0.7 -> en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given
    n1=en:urine protein test result documented and reviewed | n2=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | rel=r_associated | relid=0 | w=21
  177. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:implanted pleural catheter, each
    n1=en:urine protein test result documented and reviewed | n2=en:implanted pleural catheter, each | rel=r_associated | relid=0 | w=20
  178. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:injection, belinostat, 10 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, belinostat, 10 mg | rel=r_associated | relid=0 | w=20
  179. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:injection, pertuzumab, 10 mg
    n1=en:urine protein test result documented and reviewed | n2=en:injection, pertuzumab, 10 mg | rel=r_associated | relid=0 | w=20
  180. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:ldl value >= 100
    n1=en:urine protein test result documented and reviewed | n2=en:ldl value >= 100 | rel=r_associated | relid=0 | w=20
  181. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:most recent systolic blood pressure >= 140 mm hg
    n1=en:urine protein test result documented and reviewed | n2=en:most recent systolic blood pressure >= 140 mm hg | rel=r_associated | relid=0 | w=20
  182. en:urine protein test result documented and reviewed -- r_associated #0: 20 / 0.667 -> en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score
    n1=en:urine protein test result documented and reviewed | n2=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | rel=r_associated | relid=0 | w=20
≈ 182 relations entrantes

  1. en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. --- r_associated #0: 43 --> en:urine protein test result documented and reviewed
    n1=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=43
  2. en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase --- r_associated #0: 41 --> en:urine protein test result documented and reviewed
    n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=41
  3. en:score on the swallowing functional communication measure at discharge was higher than at admission --- r_associated #0: 41 --> en:urine protein test result documented and reviewed
    n1=en:score on the swallowing functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=41
  4. en:injection, taliglucerase alfa, 10 units --- r_associated #0: 40 --> en:urine protein test result documented and reviewed
    n1=en:injection, taliglucerase alfa, 10 units | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=40
  5. en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) --- r_associated #0: 40 --> en:urine protein test result documented and reviewed
    n1=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=40
  6. en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record --- r_associated #0: 39 --> en:urine protein test result documented and reviewed
    n1=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=39
  7. en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg --- r_associated #0: 39 --> en:urine protein test result documented and reviewed
    n1=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=39
  8. en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission --- r_associated #0: 39 --> en:urine protein test result documented and reviewed
    n1=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=39
  9. en:follow-up cta, duplex, or mra of the abdomen and pelvis performed --- r_associated #0: 38 --> en:urine protein test result documented and reviewed
    n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=38
  10. en:patient not treated for memory disorder --- r_associated #0: 38 --> en:urine protein test result documented and reviewed
    n1=en:patient not treated for memory disorder | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=38
  11. en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge --- r_associated #0: 37 --> en:urine protein test result documented and reviewed
    n1=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=37
  12. en:abdominal aortic aneurysm is not infarenal --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:abdominal aortic aneurysm is not infarenal | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  13. en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  14. en:anti-lipid treatment at discharge --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:anti-lipid treatment at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  15. en:antiplatelet medication contraindicated --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:antiplatelet medication contraindicated | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  16. en:beta-blocker at discharge --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:beta-blocker at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  17. en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  18. en:complete gene sequence analysis; mlh1 gene --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:complete gene sequence analysis; mlh1 gene | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  19. en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  20. en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  21. en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  22. en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  23. en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  24. en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  25. en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  26. en:injection, brentuximab vedotin, 1 mg --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:injection, brentuximab vedotin, 1 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  27. en:injection, peginesatide, 0.1 mg (for esrd on dialysis) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  28. en:injection, sculptra, 0.1 ml --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:injection, sculptra, 0.1 ml | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  29. en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  30. en:level of activity and symptoms not assessed --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:level of activity and symptoms not assessed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  31. en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  32. en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  33. en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  34. en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  35. en:score on the motor speech functional communication measure at discharge was higher than at admission --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:score on the motor speech functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  36. en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  37. en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  38. en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries --- r_associated #0: 36 --> en:urine protein test result documented and reviewed
    n1=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=36
  39. en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  40. en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  41. en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  42. en:electronic wrist rotator, otto bock or equal --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:electronic wrist rotator, otto bock or equal | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  43. en:hcpcs level ii preferred terms, obsolete --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:hcpcs level ii preferred terms, obsolete | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  44. en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  45. en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  46. en:injection, factor viii, fc fusion protein, (recombinant), per i.u. --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  47. en:injection, sulfur hexafluoride lipid microsphere, per ml --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:injection, sulfur hexafluoride lipid microsphere, per ml | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  48. en:lipid profile not performed, reason not given --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:lipid profile not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  49. en:patient documentation - angina assessed as absent --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:patient documentation - angina assessed as absent | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  50. en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  51. en:patient receiving antiviral treatment for hepatitis c documented --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:patient receiving antiviral treatment for hepatitis c documented | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  52. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  53. en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  54. en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  55. en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  56. en:rehabilitation services were not ordered, reason not otherwise specified --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:rehabilitation services were not ordered, reason not otherwise specified | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  57. en:score on the attention functional communication measure at discharge was higher than at admission --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:score on the attention functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  58. en:severity of angina assessed according to level of activity --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:severity of angina assessed according to level of activity | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  59. en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens --- r_associated #0: 35 --> en:urine protein test result documented and reviewed
    n1=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=35
  60. en:assessed level of activity and symptoms --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:assessed level of activity and symptoms | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  61. en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  62. en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  63. en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  64. en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  65. en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  66. en:implanted pleural catheter, each --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:implanted pleural catheter, each | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  67. en:injection, morphine sulfate, 100mg --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:injection, morphine sulfate, 100mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  68. en:injection, testosterone enanthate, up to 100 mg administered --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:injection, testosterone enanthate, up to 100 mg administered | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  69. en:ldl value >= 100 --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:ldl value >= 100 | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  70. en:most recent office visit diastolic blood pressure, 80 - 89 mm hg --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  71. en:netupitant 300 mg and palonosetron 0.5 mg --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:netupitant 300 mg and palonosetron 0.5 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  72. en:no documentation of disease type, anatomic location, and activity, reason not given --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:no documentation of disease type, anatomic location, and activity, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  73. en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  74. en:prescription(s) generated and transmitted via a qualified erx system --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:prescription(s) generated and transmitted via a qualified erx system | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  75. en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  76. en:prostate cancer antigen 3 (pca3) testing --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:prostate cancer antigen 3 (pca3) testing | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  77. en:suicide risk assessed at the initial evaluation --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:suicide risk assessed at the initial evaluation | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  78. en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  79. en:urine protein test was not performed, reason not given --- r_associated #0: 34 --> en:urine protein test result documented and reviewed
    n1=en:urine protein test was not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=34
  80. en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  81. en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  82. en:fluocinolone acetonide, intravitreal implant --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:fluocinolone acetonide, intravitreal implant | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  83. en:genetic testing for canavan disease --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:genetic testing for canavan disease | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  84. en:grafix prime, per square centimeter --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:grafix prime, per square centimeter | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  85. en:i intend to report the back pain measures group --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:i intend to report the back pain measures group | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  86. en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  87. en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  88. en:levonorgestrel 52mg intrauterine system --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:levonorgestrel 52mg intrauterine system | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  89. en:miscellaneous supply or accessory for use with ventricular assist device --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:miscellaneous supply or accessory for use with ventricular assist device | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  90. en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  91. en:score on the writing functional communication measure at discharge was higher than at admission --- r_associated #0: 32 --> en:urine protein test result documented and reviewed
    n1=en:score on the writing functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=32
  92. en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  93. en:compounded drug, not otherwise classified --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:compounded drug, not otherwise classified | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  94. en:genetic testing for gaucher disease --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:genetic testing for gaucher disease | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  95. en:i intend to report the community-acquired pneumonia (cap) measures group --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:i intend to report the community-acquired pneumonia (cap) measures group | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  96. en:injection, ocriplasmin, 0.125 mg --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:injection, ocriplasmin, 0.125 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  97. en:ldl-c not performed, reason not given --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:ldl-c not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  98. en:ldl-c was not performed --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:ldl-c was not performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  99. en:patch closure used for patient undergoing conventional cea --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:patch closure used for patient undergoing conventional cea | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  100. en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  101. en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  102. en:patients with a positive hepatitis c antibody test --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:patients with a positive hepatitis c antibody test | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  103. en:positive airway pressure therapy not prescribed --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:positive airway pressure therapy not prescribed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  104. en:prednisone, oral, per 5 mg --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:prednisone, oral, per 5 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  105. en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  106. en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  107. en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  108. en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  109. en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 31 --> en:urine protein test result documented and reviewed
    n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=31
  110. en:diabetes screening test not performed, reason not given --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:diabetes screening test not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  111. en:i intend to report the hypertension (htn) measures group --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:i intend to report the hypertension (htn) measures group | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  112. en:injection, zoledronic acid (zometa), 1 mg administered --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:injection, zoledronic acid (zometa), 1 mg administered | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  113. en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  114. en:most recent blood pressure under control --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:most recent blood pressure under control | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  115. en:most recent ldl-c under control, results documented and reviewed --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:most recent ldl-c under control, results documented and reviewed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  116. en:most recent systolic blood pressure >= 140 mm hg --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:most recent systolic blood pressure >= 140 mm hg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  117. en:oral aspirin or other antithrombotic therapy prescribed --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:oral aspirin or other antithrombotic therapy prescribed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  118. en:patient documentation - angina assessed as present --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:patient documentation - angina assessed as present | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  119. en:patient had a medical visit in the last 6 months --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:patient had a medical visit in the last 6 months | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  120. en:patient not treated for motor speech disorder --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:patient not treated for motor speech disorder | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  121. en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  122. en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  123. en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  124. en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device --- r_associated #0: 30 --> en:urine protein test result documented and reviewed
    n1=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=30
  125. en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  126. en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  127. en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  128. en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  129. en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  130. en:injection, ferric carboxymaltose, 1 mg --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:injection, ferric carboxymaltose, 1 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  131. en:injection, testosterone cypionate, up to 100 mg --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:injection, testosterone cypionate, up to 100 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  132. en:most recent ldl-c not under control, results documented and reviewed --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:most recent ldl-c not under control, results documented and reviewed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  133. en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  134. en:pregnancy test (urine or serum) was not ordered, reason not specified --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:pregnancy test (urine or serum) was not ordered, reason not specified | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  135. en:score on the reading functional communication measure at discharge was higher than at admission --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:score on the reading functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  136. en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea --- r_associated #0: 29 --> en:urine protein test result documented and reviewed
    n1=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=29
  137. en:counseling for diet and physical activity not performed, reason not given --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:counseling for diet and physical activity not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  138. en:counseling for diet and physical activity performed --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:counseling for diet and physical activity performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  139. en:documentation of diagnosis of chronic kidney disease --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:documentation of diagnosis of chronic kidney disease | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  140. en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  141. en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  142. en:i intend to report the epilepsy measures group --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:i intend to report the epilepsy measures group | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  143. en:i intend to report the perioperative care measures group --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:i intend to report the perioperative care measures group | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  144. en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  145. en:injection, alemtuzumab, 10 mg administered --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:injection, alemtuzumab, 10 mg administered | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  146. en:injection, belinostat, 10 mg --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:injection, belinostat, 10 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  147. en:injection, medroxyprogesterone acetate, 50 mg --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:injection, medroxyprogesterone acetate, 50 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  148. en:injection, testosterone enanthate, up to 200 mg administered --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:injection, testosterone enanthate, up to 200 mg administered | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  149. en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  150. en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  151. en:no anti-lipid treatment at discharge --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:no anti-lipid treatment at discharge | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  152. en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  153. en:patient not treated for attention disorder --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:patient not treated for attention disorder | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  154. en:patient not treated for reading disorder --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:patient not treated for reading disorder | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  155. en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  156. en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  157. en:pneumocystis jiroveci pneumonia prophlaxis prescribed --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  158. en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  159. en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  160. en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  161. en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  162. en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  163. en:unlisted procedure, intestine --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:unlisted procedure, intestine | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  164. en:vacuum drainage bottle and tubing for use with implanted catheter --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:vacuum drainage bottle and tubing for use with implanted catheter | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  165. en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) --- r_associated #0: 28 --> en:urine protein test result documented and reviewed
    n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=28
  166. en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  167. en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  168. en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  169. en:injection, human fibrinogen concentrate, 100 mg --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:injection, human fibrinogen concentrate, 100 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  170. en:injection, ziv-aflibercept, 1 mg --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:injection, ziv-aflibercept, 1 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  171. en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  172. en:patient not treated for spoken language expression disorder --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:patient not treated for spoken language expression disorder | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  173. en:pregnancy test (urine or serum) not ordered for reasons documented by clinician --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  174. en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  175. en:score on the spoken language expression functional communication measure at discharge was higher than at admission --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  176. en:serum creatinine test not performed, reason not given --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:serum creatinine test not performed, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  177. en:suicide risk not assessed at the initial evaluation, reason not given --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:suicide risk not assessed at the initial evaluation, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  178. en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  179. en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given --- r_associated #0: 27 --> en:urine protein test result documented and reviewed
    n1=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=27
  180. en:injection, pertuzumab, 10 mg --- r_associated #0: 26 --> en:urine protein test result documented and reviewed
    n1=en:injection, pertuzumab, 10 mg | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=26
  181. protéine --- r_associated #0: 20 --> en:urine protein test result documented and reviewed
    n1=protéine | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=20
  182. proteine --- r_associated #0: 10 --> en:urine protein test result documented and reviewed
    n1=proteine | n2=en:urine protein test result documented and reviewed | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr